We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Standardized allergen extracts for allergen immunotherapy.
- Authors
Nelson, Harold S.
- Abstract
Nineteen U.S. allergen extracts were standardized by the U.S. Food and Drug Administration (FDA) between 1987 and 1998, including of two house-dust mites, short ragweed, cat hair and cat pelt, seven temperate and one southern grass, and six Hymenoptera venom preparations. Relevant literature was reviewed. For each allergen, a "representative" extract was established; the potency of each representative extract was determined bymeasurement of the total protein content (Hymenoptera venom), radial diffusion measurement of the dominant allergen (short ragweed and cat), or, if there was no dominant allergen, then by quantitative skin testing by using the ID50EAL (intradermal dilution for 50 mm sum of erythema determines the bioequivalent allergy units) method. In vitro tests were developed to allow the manufacturer to demonstrate that each lot of its extract was statistically identical, within defined limits, to the FDA reference extract. These tests included radial immunodiffusion, competitive enzyme-linked immunosorbent assay, and isoelectric focusing. The standardized extracts offer the advantage of consistent potency from lot to lot for each manufacturer and also from manufacturer to manufacturer, and assure the presence of recognized significant allergens within the extract. Therefore, standardized extracts offer improved safety and efficacy over their nonstandardized predecessors.
- Subjects
UNITED States. Food &; Drug Administration; ALLERGENIC extracts; DERMATOPHAGOIDES pteronyssinus; DIFFUSION measurements; ENZYME-linked immunosorbent assay; ISOELECTRIC focusing
- Publication
Allergy & Asthma Proceedings, 2022, Vol 43, Issue 4, p327
- ISSN
1088-5412
- Publication type
Article
- DOI
10.2500/aap.2022.43.220015